Riskpilot← Back to searchSign inGet full accessMAJORSTUEN SPECSAVERS AS
ASActiveOrg 924455527Valkyriegata 15B, 0366 OsloRetail sale of medical and orthopaedic goods · NACE 4774Est. 202021 employees
Revenue 2025
NOK 24,6M
+14% vs 2024
EBITDA margin
9.3%
+20% vs 2024
Equity ratio
19.5%
Financial strength
Net profit 2025
NOK 1,3M
+33% vs 2024
| Revenue | NOK 24,6M | +14% |
| EBITDA | NOK 2,3M | +20% |
| Net profit | NOK 1,3M | +33% |
| Total assets | NOK 7,3M | +43% |
| Equity | NOK 1,4M | -36% |
| Employees | 21 | — |
Legal name
MAJORSTUEN SPECSAVERS AS
Org number
924455527
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
21. januar 2020
Share capital
NOK 30 625
Employees
21 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Handel med optiske varer samt det som naturlig står i forbindelse med dette.
Address
Valkyriegata 15B, 0366 Oslo
Phone
+4722853560
Email
majorstua@no.specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 16 206 | 17 225 | 17 639 | 21 620 | 24 580 |
| Staff expenses | −4 320 | −3 877 | −4 487 | −5 378 | −6 065 |
| EBITDA | 657 | 1 552 | 352 | 1 906 | 2 293 |
| Depreciation & amort. | −453 | −205 | −283 | −629 | −621 |
| EBIT | 205 | 1 348 | 69 | 1 277 | 1 672 |
| Net financials | −1 | −6 | 0 | −6 | 11 |
| Profit before tax | 204 | 1 341 | 69 | 1 271 | 1 683 |
| Tax | 44 | 296 | 16 | 282 | 370 |
| Net profit | 160 | 1 045 | 53 | 989 | 1 314 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 836 | 4 221 | 4 632 | 5 118 | 7 340 |
| Equity | 513 | 1 558 | 1 225 | 2 214 | 1 428 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 323 | 2 663 | 3 408 | 2 904 | 5 912 |
| Total debt | 2 323 | 2 663 | 3 408 | 2 904 | 5 912 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20212025
Equity ratio
19.5%
This company
38.2%
Market median
-49% vs market
20212025
Return on equity
92.0%
This company
18.4%
Market median
+400% vs market
20212025
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20212025
Asset turnover
3.35×
This company
1.12×
Market median
+199% vs market
20212025
Debt / equity
4.14×
This company
0.62×
Market median
-568% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2019-12-16 – 2021-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Chairman | 2022 – 2023 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.21% | 50.21% | 2022 | |
Norway Specsavers Ltd | Company | 50.2% | 50.2% | 2024 |
| Individual | 24.9% | 24.9% | 2024 | |
| Individual | 24.9% | 24.9% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MAJORSTUEN SPECSAVERS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Neil Owens | Chairman | 0 companies |
| Henning Jørgen Eriksen | Chairman | 0 companies |
| Jan Kristian Bjerke | Chairman | 0 companies |
| Henning Jørgen Eriksen Færden | Board of Directors | 0 companies |
| Nina Helen Kleppe | Board of Directors | 0 companies |
| Jan-Kristian Bjerke | Board of Directors | 0 companies |
| Lisbeth Sæther | Board of Directors | 0 companies |